Modulate Bio is developing next-gen GABA-A positive allosteric modulators to treat neurological disorders, including Essential Tremor, epilepsy and anxiety, without the sedative effects associated with benzodiazepines and neurosteroids.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Cambridge, Massachusetts, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://modulatebio.com
- Keywords
- biotech, drug development, therapeutics, essential tremor, central nervous system, pharmaceuticals, biotechnology.
- HQ
- Cambridge, Massachusetts
Modulate Bio Questions
Modulate Bio's website is http://modulatebio.com
Modulate Bio's LinkedIn profile is https://www.linkedin.com/company/modulate-bio
Modulate Bio has
5 employees.
View email and phone details for 5
employees at Modulate Bio.
Modulate Bio's industry is
Biotechnology Research
Modulate Bio's top competitors are
Fieldstone Bio,
Magenta Therapeutics,
Rubik Therapeutics,
Novaterra,
Redpoint Oncology, Inc,
Lybra Bio,
Bullseye Biosciences,
On-Chip Biotechnologies,
Longevitan Biosciences,
Evaclean Infection Prevention.
Modulate Bio's categories are Biotechnology Research
Modulate Bio's founding year is 2023
